Analyst Ranking
Top 8%
#376 out of 4868 analysts
Average Return
+3.44%
Win Rate
42%188 out of 453
Risk vs Reward
Poor
Good

Ed Arce's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Cymabay Therapeutics IncCBAY
+481.01%$1.79$10.40
2022-05-16 -
2023-05-15
Buy
Vera Therapeutics IncVERA
+445.84%$7.57$41.32
2023-05-12 -
2024-05-10
Buy
Viking Therapeutics IncVKTX
+350.00%$2.74$12.33
2017-11-10 -
2018-11-09
Buy
Vera Therapeutics IncVERA
+342.53%$8.70$38.50
2023-06-08 -
2024-06-07
Buy
89bio IncETNB
+338.51%$3.48$15.26
2022-07-28 -
2023-07-27
Buy

Ed Arce Analyst Color

Get additional color on Ed Arce's coverage of popular stocks

Ed Arce's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Metavia IncMTVA
3Buy$12.00+1,476.87%Reiterates
15 days ago
Unicycive Therapeutics IncUNCY
27Buy$7.50+1,050.31%Reiterates
20 days ago
Arcturus Therapeutics Holdings IncARCT
28Buy$60.00+368.38%Reiterates
21 days ago
Akebia Therapeutics IncAKBA
29Buy$7.50+211.20%Reiterates
a month ago
Inventiva SaIVA
16Buy$13.00+251.35%Reiterates
a month ago
Talphera IncTLPH
13Buy$6.00+1,124.49%Reiterates
a month ago
Aligos Therapeutics IncALGS
6Buy$70.00+1,154.48%Reiterates
a month ago
Acurx Pharmaceuticals IncACXP
17Buy$12.00+2,690.70%Reiterates
a month ago
Sagimet Biosciences IncSGMT
11Buy$32.00+827.54%Reiterates
2 months ago
Cidara Therapeutics IncCDTX
21Buy$35.00+67.58%Maintains
2 months ago
Akero Therapeutics IncAKRO
23Buy$75.00+64.44%Maintains
2 months ago
89bio IncETNB
22Buy$21.00+161.85%Reiterates
2 months ago
Mirum Pharmaceuticals IncMIRM
30Buy$72.00+65.71%Maintains
2 months ago
Madrigal Pharmaceuticals IncMDGL
15Buy$405.00+21.29%Maintains
2 months ago
Ardelyx IncARDX
9Hold$5.50-0.09%Reiterates
2 months ago
Ultragenyx Pharmaceutical IncRARE
6Buy$95.00+143.71%Reiterates
2 months ago
Enanta Pharmaceuticals IncENTA
11Buy$18.00+195.57%Reiterates
3 months ago
Genfit SaGNFT
17Buy$13.00+217.46%Reiterates
3 months ago
Arbutus Biopharma CorpABUS
18Buy$5.00+40.85%Reiterates
3 months ago
Travere Therapeutics IncTVTX
20Buy$22.00+5.72%Maintains
4 months ago
Newamsterdam Pharma Co NvNAMS
2Buy$48.00+150.91%Reiterates
4 months ago
Terns Pharmaceuticals IncTERN
11Hold$7.50+127.27%Reiterates
5 months ago
Galectin Therapeutics IncGALT
10Buy$11.00+702.92%Reiterates
6 months ago
Pliant Therapeutics IncPLRX
20Buy$38.00+2,289.94%Reiterates
6 months ago
Iterum Therapeutics PLCITRM
11Buy$5.00+346.43%Reiterates
8 months ago
Aurinia Pharmaceuticals IncAUPH
12Buy$13.00+57.77%Reiterates
8 months ago
Zyversa Therapeutics IncZVSA
4Buy$240.00N/AReiterates
a year ago
Cymabay Therapeutics IncCBAY
13Hold$32.50N/AReiterates
a year ago
Vera Therapeutics IncVERA
7Buy$25.00N/AReiterates
a year ago
Intercept Pharmaceuticals IncICPT
10Hold$19.00N/ADowngrades
2 years ago
Synlogic IncSYBX
6Buy$75.00N/AReiterates
2 years ago
Durect CorpDRRX
6Buy$27.00N/AMaintains
2 years ago
Paratek Pharmaceuticals IncPRTK
9Hold$2.15N/AReiterates
2 years ago
Chinook Therapeutics IncKDNY
3Hold$40.00N/AReiterates
2 years ago
Assembly Biosciences IncASMB
2Hold$18.00N/AMaintains
2 years ago
Albireo Pharma IncALBO
7Hold$42.00N/AReiterates
2 years ago
Axcella Health IncAXLA
4HoldN/AN/ADowngrades
2 years ago
Mimecast LtdMIME
1Buy$69.00N/AMaintains
3 years ago
Entasis Therapeutics Holdings IncETTX
3Hold$1.80N/ADowngrades
3 years ago
Dicerna Pharmaceuticals IncDRNA
6Hold$38.25N/ADowngrades
3 years ago
Metacrine IncMTCR
2HoldN/AN/ADowngrades
4 years ago
Galmed Pharmaceuticals LtdGLMD
3Buy$4,500.00N/AMaintains
4 years ago
Avenue Therapeutics IncATXI
2Buy$14,625.00N/AMaintains
5 years ago
Trevena IncTRVN
4Buy$2,187.50N/AAssumes
6 years ago
Tetraphase Pharmaceuticals IncTTPH
2Buy$7.00N/AMaintains
7 years ago
Viking Therapeutics IncVKTX
1Buy$7.00N/AAssumes
7 years ago
Ocera Therapeutics IncOCRX
1HoldN/AN/ADowngrades
7 years ago
Collegium Pharmaceutical IncCOLL
1Buy$21.00N/AInitiates Coverage On
8 years ago
Nabriva Therapeutics PLCNBRVF
2Buy$4,500.00N/AMaintains
8 years ago
Atea Pharmaceuticals IncAVIR
1HoldN/AN/ADowngrades
8 years ago
Medicines CoMDCO
1Buy$57.00N/AInitiates Coverage On
8 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.